MIGLINO M.

Last name: MIGLINO M.

2019 (v1)

Publication

Metadata-only

Cutaneous manifestations of hematologic malignancies the experience of an Italian dermatology department

Merlo G. Cozzani E. Canale F.

In recent years, dermatologic manifestations in oncohematologic patients have become more common. The aim of our study was to determine the incidence and heterogeneity of skin manifestations in patients followed at our Hematology Department. This observational monocentrical study was conducted on 60 patients. We divided the observed conditions...

Uploaded on: April 14, 2023
2018 (v1)

Publication

Metadata-only

A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis

Minetto P. Guolo F. Clavio M.

No description

Uploaded on: March 27, 2023
2015 (v1)

Publication

Metadata-only

Hepatosplenic T-cell lymphoma with aberrant expression of serum β-HCG: A case report

Bellodi A. Rivoli G. Arboscello E.

Background: Peripheral T-cell lymphomas (PTCL) represent a heterogeneous group of hematologic malignancies frequently presenting at advanced stage of diagnosis.Methods: We report a case of PTCL with an uncommon and aggressive onset with disseminated intravascular coagulation (DIC).Results: Laboratory findings revealed an aberrant expression of...

Uploaded on: April 14, 2023
2020 (v1)

Publication

Metadata-only

Prognostic relevance of a blastic plasmacytoid dendritic cell neoplasm-like immunophenotype in cytogenetically normal acute myeloid leukemia patients

Guolo F. Minetto P. Clavio M.

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a poor prognosis myeloid malignancy characterized by an atypical phenotype (CD123+, CD56+, and CD4+). We reported that BPDCN-like phenotype (CD123+ and either CD56+ or CD4+ or both) confers poor prognosis to acute myeloblastic leukemia (AML) patients with mutated NPM1. Here, we evaluated...

Uploaded on: February 14, 2024

MIGLINO M.

Recent uploads